Clinical Trial Update: NE3107 in Adults With Neurological Symptoms of Long COVID [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NE3107 in adults with neurological symptoms of Long COVID, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Drugs mentioned

• NE3107 (NE3107)

Snippet

Sponsor: BioVie Inc. | Conditions: Long COVID | Phase 2 | Status: RECRUITING